Tibet Weixinkang Medicine Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 749.18 million compared to CNY 667.92 million a year ago. Revenue was CNY 749.41 million compared to CNY 668.04 million a year ago.

Net income was CNY 134 million compared to CNY 102.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.31 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.31 compared to CNY 0.24 a year ago.